PMID: 15378140Sep 21, 2004Paper

Effect of potassium-channel opener therapy on reperfused infarction in hypertrophied hearts: demonstration of preconditioning by using functional and contrast-enhanced magnetic resonance imaging

Journal of Cardiovascular Pharmacology and Therapeutics
Simon SchallaMaythem Saeed

Abstract

Effects of therapy with the potassium-channel opener and vasodilator nicorandil were studied in reperfused infarction of hypertrophied hearts by using magnetic resonance imaging (MRI), hemodynamic measurements, and histochemical staining. Aortic banding was performed on 22 Sprague-Dawley rats to induce left ventricular (LV) hypertrophy; 11 were the controls. Eight weeks later, the left coronary artery was occluded for 25 minutes in all 33 animals, followed by 3 hours of reperfusion. During occlusion, 11 rats with LV hypertrophy received nicorandil (0.1 mg/kg bolus and 1.5 mg/kg/h for 3 hours). The new necrosis-specific contrast agent Gadophrin-3 was administered to all animals to delineate infarction on multislice T1-weighted spin-echo MRI. Nicorandil increased ischemic tolerance of LV hypertrophy as shown by the reduction of infarction size from 19.3% +/- 1.3% to 10.0% +/- 2.5% LV (P = .005). Infarction size in treated animals was identical to control (9.3% +/- 1.6%). Close correlation was found between MRI and postmortem findings. Functional MRI revealed an improvement in ejection fraction in nicorandil-treated hearts (48.5% +/- 3.4% vs 38.1% +/- 3.2%, P = .04). LV end-diastolic volume and pressure, aortic pressure, and perip...Continue Reading

References

Jun 1, 1992·Cardiovascular Drugs and Therapy·G M Pieper, G J Gross
Aug 1, 1990·Cardiovascular Drugs and Therapy·F YoneyamaN Taira
May 1, 1983·Journal of Pharmacological Methods·I LepránL Szekeres
Aug 24, 1999·The Journal of Physiology·E L HolmuhamedovA Terzic
May 17, 2000·Journal of Cardiovascular Pharmacology·K SakaiS Matsubara
Dec 21, 2000·American Journal of Physiology. Heart and Circulatory Physiology·S SanadaM Hori
Sep 12, 2001·Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society for Cardiovascular Magnetic Resonance·C H LorenzT P Graham
Dec 12, 2001·Journal of the American College of Cardiology·P VerdecchiaUNKNOWN MAVI (MAssa Ventricolare sinistra nell'Ipertensione) Study Group
Feb 19, 2002·Journal of the American College of Cardiology·Gavin R NortonTheo E Meyer
Apr 30, 2002·Magnetic Resonance in Medicine : Official Journal of the Society of Magnetic Resonance in Medicine·Gabriele A KrombachMaythem Saeed

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antianginal Drugs: Mechanisms of Action

Antianginal drugs, including nitrates, beta-blockers, and calcium channel blockers, are used in the treatment of angina pectoris. Here is the latest research on their use and their mechanism of action.

Cardiomegaly

Cardiomegaly, known as an enlarged heart, is a multifactorial disease with different pathophysiological mechanisms. Hypertension, pregnancy, exercise-induced and idiopathic causes are some mechanisms of cardiomegaly. Discover the latest research of cardiomegaly here.